Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion

被引:50
作者
Henry, David A. [1 ]
Carless, Paul A. [2 ]
Moxey, Annette J. [3 ]
O'Connell, Dianne [4 ]
Stokes, Barrie J. [2 ]
Fergusson, Dean A. [5 ]
Ker, Katharine [6 ]
机构
[1] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada
[2] Univ Newcastle, Discipline Clin Pharmacol, Fac Hlth, Newcastle, NSW 2308, Australia
[3] Univ Newcastle, Res Ctr Gender Hlth & Ageing, Fac Hlth, Newcastle, NSW 2308, Australia
[4] Canc Council, Canc Epidemiol Res Unit, Sydney, NSW, Australia
[5] Univ Ottawa, Ottawa Hlth Res Inst, Ctr Transfus Res, Ottawa, ON, Canada
[6] London Sch Hyg & Trop Med, Cochrane Injuries Grp, London WC1, England
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2011年 / 01期
基金
英国医学研究理事会;
关键词
6-Aminocaproic Acid [therapeutic use; Antifibrinolytic Agents [therapeutic use; Aprotinin [therapeutic use; Erythrocyte Transfusion [utilization; Randomized Controlled Trials as Topic; Tranexamic Acid [therapeutic use; Transplantation; Homologous; Humans; EPSILON-AMINOCAPROIC ACID; LOW-DOSE APROTININ; ARTERY-BYPASS GRAFT; TOTAL HIP-ARTHROPLASTY; PLACEBO-CONTROLLED TRIAL; ORTHOTOPIC LIVER-TRANSPLANTATION; PROPHYLACTIC TRANEXAMIC ACID; PATIENTS RECEIVING ASPIRIN; TOTAL KNEE ARTHROPLASTY; HYPOTHERMIC CIRCULATORY ARREST;
D O I
10.1002/14651858.CD001886.pub3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:419
相关论文
共 304 条
[91]   IS THERE A PHASE OF HYPERCOAGULABILITY WHEN APROTININ IS USED IN CARDIAC-SURGERY [J].
FEINDT, P ;
SEYFERT, U ;
VOLKMER, I ;
HUWER, H ;
KALWEIT, G ;
GAMS, E .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1994, 8 (06) :308-313
[92]  
FEJER C, 1998, BRIT J ANAESTHESI S1, V80, P80
[93]   Aprotinin - Are there lessons learned? [J].
Ferguson, T. Bruce, Jr. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (05) :527-529
[94]   Economic evaluations of technologies to minimize perioperative transfusion: A systematic review of published studies [J].
Fergusson, D ;
VanWalraven, C ;
Coyle, D ;
Laupacis, A .
TRANSFUSION MEDICINE REVIEWS, 1999, 13 (02) :106-117
[95]   A comparison of aprotinin and lysine analogues in high-risk cardiac surgery [J].
Fergusson, Dean A. ;
Hebert, Paul C. ;
Mazer, C. David ;
Fremes, Stephen ;
MacAdams, Charles ;
Murkin, John M. ;
Teoh, Kevin ;
Duke, Peter C. ;
Arellano, Ramiro ;
Blajchman, Morris A. ;
Bussieres, Jean S. ;
Cote, Dany ;
Karski, Jacek ;
Martineau, Raymond ;
Robblee, James A. ;
Rodger, Marc ;
Wells, George ;
Clinch, Jennifer ;
Pretorius, Roanda .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (22) :2319-2331
[96]  
Ferraris VA, 2006, NEW ENGL J MED, V354, P1953
[97]   Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: A prospective, randomized, double-blind study [J].
Findlay, JY ;
Rettke, SR ;
Ereth, MH ;
Plevak, DJ ;
Krom, RAF ;
Kufner, RP .
LIVER TRANSPLANTATION, 2001, 7 (09) :802-807
[98]   Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion -: Results of a meta-analysis [J].
Forgie, MA ;
Wells, PS ;
Laupacis, A ;
Fergusson, D .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (06) :610-616
[99]   REDUCTION OF BLOOD-TRANSFUSION REQUIREMENT IN OPEN-HEART SURGERY BY ADMINISTRATION OF HIGH-DOSES OF APROTININ - PRELIMINARY-RESULTS [J].
FRAEDRICH, G ;
WEBER, C ;
BERNARD, C ;
HETTWER, A ;
SCHLOSSER, V .
THORACIC AND CARDIOVASCULAR SURGEON, 1989, 37 (02) :89-91
[100]  
FRITZ H, 1983, ARZNEIMITTELFORSCH, V33-1, P479